Atlas Trials

A Single-dose Study of Octreotide Injection in Healthy Adult Subjects

Clinical trial NCT05761431 · COMPLETED

Trial details

NCT number
NCT05761431
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acromegaly
Start date
2023-03-02
Primary completion
2023-06-28
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.